产品封面图

FITC标记的胰高血糖素样肽-1抗体

收藏
  • ¥2980
  • LMAI Bio
  • LM-0038R-FITC
  • 中国/美国/欧洲
  • 2025年07月12日
  • IF=1:50-200
  • Human, Mouse, Rat, Pig, Cow, Sheep,
  • Human, Mouse, Rat, Pig, Cow, Sheep,
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海联迈生物工程有限公司

    • 库存

      大量

    • 靶点

      详见说明书

    • 级别

      1

    • 目录编号

      LM-0038R-FITC

    • 克隆性

      多克隆

    • 抗原来源

      Rabbit

    • 保质期

      1年

    • 抗体英文名

      Anti-GLP-1 (7-36)/FITC

    • 抗体名

      Anti-GLP-1 (7-36)/FITC

    • 标记物

      FITC标记

    • 宿主

      Human, Mouse, Rat, Pig, Cow, Sheep,

    • 适应物种

      Human, Mouse, Rat, Pig, Cow, Sheep,

    • 免疫原

      详见说明书

    • 亚型

      IGg

    • 形态

      粉末、液体、冻干粉

    • 应用范围

      IF=1:50-200

    • 浓度

      1mg/ml

    • 保存条件

      -20 °C

    • 规格

      100ul

    FITC标记的胰高血糖素样肽-1抗体
    英文名称 Anti-GLP-1 (7-36)/FITC
    中文名称 FITC标记的胰高血糖素样肽-1抗体
    别    名 GCG; GLP 1; glucagon; Glucagon like peptide 1; GRPP; GLP-1(7-36); GLP-1(7-37); Oxyntomodulin; OXM; OXY; GLUC_HUMAN.  
    规格价格 100ul/2980元 购买        大包装/询价
    说 明 书 100ul  
    研究领域 肿瘤  心血管  细胞生物  神经生物学  信号转导  糖尿病  内分泌病  新陈代谢  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Rat, Pig, Cow, Sheep, 
    产品应用 IF=1:50-200  
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 21kDa
    性    状 Lyophilized or Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from human GLP-1 (7-36)
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    产品介绍 background:
    The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon. [provided by RefSeq].

    Function:
    Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. 
    GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion. Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation. Inhibits beta cell apoptosis. 
    GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability. 
    Oxyntomodulin significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness. 
    Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life.

    Subcellular Location:
    Secreted.

    Tissue Specificity:
    Glucagon is secreted in the A cells of the islets of Langerhans. GLP-1, GLP-2, oxyntomodulin and glicentin are secreted from enteroendocrine cells throughout the gastrointestinal tract. GLP1 and GLP2 are also secreted in selected neurons in the brain.

    Post-translational modifications:
    Proglucagon is post-translationally processed in a tissue-specific manner in pancreatic A cells and intestinal L cells. In pancreatic A cells, the major bioactive hormone is glucagon cleaved by PCSK2/PC2. In the intestinal L cells PCSK1/PC1 liberates GLP-1, GLP-2, glicentin and oxyntomodulin. GLP-1 is further N-terminally truncated by post-translational processing in the intestinal L cells resulting in GLP-1(7-37) GLP-1-(7-36)amide. The C-terminal amidation is neither important for the metabolism of GLP-1 nor for its effects on the endocrine pancreas.

    Similarity:
    Belongs to the glucagon family.

    Database links:

    Entrez Gene: 2641 Human

    Entrez Gene: 14526 Mouse

    Entrez Gene: 24952 Rat

    Omim: 138030 Human

    SwissProt: P01275 Human

    SwissProt: P55095 Mouse

    SwissProt: P06883 Rat

    Unigene: 516494 Human

    Unigene: 45494 Mouse

    Unigene: 54383 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

    胰高血糖素(Glucagon)在糖代谢和体内平衡中起重要作用,通过释放糖原和糖酵解调节血糖。作为反调节激素的胰岛素,当血糖升高时,胰岛素可诱导低血糖。胰高血糖素样肽-1(Glucagon-like peptide-1, GLP-1)是一个具有强的刺激糖依赖的胰岛素释放的肽,在胃运动性和抑制血糖水平上起重要作用。还可能参与外周组织糖的控制,不依赖胰岛素的作用。具有促进肠上皮生长等作用。GLP-1属于胰高血糖素家族成员。

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • MACS(磁珠分选)技术相关产品(stem cell公司)

      内腔可产生高强度的磁场,足以分离磁微粒标记的细胞,无需分离柱提供提供更高强度的磁场。由于磁微粒极小,不会影响靶细胞的流式分析结果,因此不需要去除。除了现有的定型产品外,客户可选择EasySep® PE、FITC或生物素分选系统与自己的PE、FITC或生物素—偶联的单抗相结合,来富集任何所需的细胞。如果您有自己的小鼠IgG1抗任何细胞的抗体, 也可以使用“Do-It-Yourself”试剂盒做成TAC,用来分选您想要的细胞。此外,还可以根据您的特殊需要,专门为您设计定做试剂盒。用于正选小鼠的细胞标记

    • 类器官培养与应用——胰岛类器官

      胰腺是分泌血糖稳态激素的重要器官,是人体内控制血糖动态平衡的中心。胰腺的内分泌功能主要是由胰岛来完成的,每个胰岛都是一个复杂的微器官,由上千个分泌细胞组成。经典的胰岛内分泌细胞包括 α 细胞、β 细胞、δ 细胞、ε 细胞和 PP 细胞,分别主要产生胰高血糖素(glucagon)、胰岛素、生长抑素(SS)、生长素释放及胰多,其在成体胰岛内分别约占 20%、75%、3%~5%、1% 和<2%【1】。 胰岛移植为 I 型和晚期 II 型糖尿病患者提供了卓越的长期血糖控制,但是成体胰岛组织的可

    • 超亲和性的新型亲和标签系统“PA Tag System”

      蛋白一起进行纯化,平足蛋白的分子量(约37kDa)和目的蛋白的分子量只要分开一定程度,之后可以用硅胶过滤等方法分离。蛋白纯化会根据蛋白自身的原因而导致结果不同,如果无法顺利进行纯化的话则需要尝试使用多种方法。如果研究人员使用当前方法无法顺利进行,可以尝试使用PA Tag System,同时也可以在新开始做动物细胞表达系蛋白纯化时作为启动试剂盒使用。我们已经知道了NZ-1抗体和PA的复合体的结晶型结构,由于结合在NZ-1上的PA有非常独特的立体结构,我们正在研究如何通过这个特别的构造使PA Tag

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海圻明生物科技有限公司
    2025年07月12日询价
    ¥2980
    上海联迈生物工程有限公司
    2025年07月16日询价
    ¥1860
    上海沪震实业有限公司
    2025年07月10日询价
    询价
    上海古朵生物科技有限公司
    2025年07月08日询价
    ¥600
    北京百奥莱博科技有限公司
    2025年07月15日询价
    FITC标记的胰高血糖素样肽-1抗体
    ¥2980